Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae TestemitanufiledCriticalUniv Nicolae Testemitanu
Priority to MD98-0195ApriorityCriticalpatent/MD1294G2/en
Publication of MD1294F1publicationCriticalpatent/MD1294F1/en
Publication of MD1294G2publicationCriticalpatent/MD1294G2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to medicine, in particular, to virology and can be used for treatment of lymphocytic choriomeningitis. Summary of the invention consists in the application of isonicotinoilhydrazone of 5-nitro-2-furaldehyde in the capacity of an inhibitor of the lymphocytic choriomeningitis virus. The result of the invention consists in expanding the arsenal of remedies effective with respect to the lymphocytic choriomeningitis virus. Claims: 1
MD98-0195A1998-02-231998-02-23Inhibitor of the lymphocytic choriomeningitis virus
MD1294G2
(en)
5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections